111 Capital Purchases Shares of 7,555 Danaher Co. (NYSE:DHR)

111 Capital purchased a new position in Danaher Co. (NYSE:DHR - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 7,555 shares of the conglomerate's stock, valued at approximately $1,734,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in DHR. Heck Capital Advisors LLC purchased a new position in Danaher in the fourth quarter worth about $27,000. Golden State Wealth Management LLC bought a new stake in shares of Danaher during the fourth quarter valued at approximately $31,000. Strategic Financial Concepts LLC purchased a new position in Danaher in the 4th quarter worth approximately $31,000. Pineridge Advisors LLC raised its holdings in Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock worth $34,000 after acquiring an additional 57 shares during the last quarter. Finally, Kentucky Trust Co purchased a new stake in Danaher during the 4th quarter valued at $34,000. Institutional investors own 79.05% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on DHR shares. HSBC decreased their price target on Danaher from $270.00 to $240.00 in a research note on Friday, April 25th. JPMorgan Chase & Co. decreased their target price on Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a research report on Tuesday, April 22nd. Guggenheim reaffirmed a "buy" rating and set a $250.00 price target on shares of Danaher in a report on Wednesday, April 23rd. Stifel Nicolaus raised shares of Danaher from a "hold" rating to a "buy" rating and set a $260.00 price objective for the company in a report on Friday, March 14th. Finally, Robert W. Baird lowered their price objective on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, Danaher presently has a consensus rating of "Moderate Buy" and a consensus price target of $263.24.

Insider Transactions at Danaher

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president now directly owns 15,179 shares in the company, valued at $3,005,442. This represents a 51.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the sale, the chairman now directly owns 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 11.20% of the company's stock.

Danaher Stock Performance

Danaher stock traded down $0.93 during trading on Friday, reaching $189.54. The company had a trading volume of 6,514,078 shares, compared to its average volume of 3,485,177. The firm's 50-day simple moving average is $193.18 and its 200 day simple moving average is $214.13. Danaher Co. has a 52 week low of $171.00 and a 52 week high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $135.65 billion, a price-to-earnings ratio of 35.90, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The firm had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. Sell-side analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.68%. Danaher's payout ratio is currently 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.